IP Library Granted Patent US 11,672,756
Granted Patent B2
US 11,672,756 · App. 16/075,296 · Granted Jun 13, 2023

Temperature sensitive hydrogel composition including nucleic acid and chitosan

Inventors: Ik Soo Kim (Seongnam-si, KR); Han Gyu Kim (Wonju-si, KR); Cheol Am Hong (Daegu, KR); Su Yeon Lee (Seongnam-si, KR)
Assignee: PHARMARESEARCH CO., LTD.
A61K9/0024A61K31/7088A61K47/36C08J3/075C08L5/00C08L5/08C08J2305/00C08J2305/08C08J2377/04C08J2405/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,756
App. No.
16/075,296
Granted
Jun 13, 2023
Kind
B2
Abstract

The present invention provides a temperature sensitive hydrogel composition including a nucleic acid and chitosan. Since the hydrogel has excellent biocompatibility and biostability, and simultaneously has sol-gel phase transition properties depending on temperature changes, the hydrogel is present in a sol state at room temperature and becomes a gel when the hydrogel is injected into the human body or applied on the surface of epithelial skin and the temperature increases. Thus, the temperature-sensitive hydrogel of the present invention can be directly injected into and applied on certain parts requiring treatment and the retention and attaching time of a drug is increased through gelation depending on the temperature so that drug efficacy is sufficiently exhibited. Therefore, it is expected that the temperature-sensitive hydrogel of the present invention can be utilized for various treatments.

Claims (21)

1. A temperature-sensitive hydrogel composition comprising a nucleic acid and chitosan,

wherein the content of the nucleic acid is 1 wt % to 3 wt % relative to the total weight of the composition, wherein the content of the chitosan is 0.001 wt % to 0.03 wt % relative to the total weight of the composition, wherein the weight ratio of the nucleic acid and the chitosan is 33.333:1 to 3000:1, and

wherein the temperature-sensitive hydrogel composition has a pH value of 6-8.

2. The temperature-sensitive hydrogel composition of claim 1 , wherein the weight ratio of the nucleic acid and the chitosan is 50:1 to 2000:1.

3. The temperature-sensitive hydrogel composition of claim 2 , wherein the weight ratio of the nucleic acid and the chitosan is 100:1 to 1000:1.

4. The temperature-sensitive hydrogel composition of claim 1 , wherein the content of the nucleic acid is 1-2 wt % relative to the total weight of the composition.

5. The temperature-sensitive hydrogel composition of claim 1 , wherein the nucleic acid is deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or a mixture thereof.

6. The temperature-sensitive hydrogel composition of claim 1 , wherein the content of the chitosan is 0.003 wt % to 0.02 wt % relative to the total weight of the composition.

7. The temperature-sensitive hydrogel composition of claim 6 , wherein the molecular weight of the chitosan is 3 kDa to 1,000 kDa.

8. The temperature-sensitive hydrogel composition of claim 1 , wherein the temperature-sensitive hydrogel composition contains a polymer material as an additional ingredient.

9. The temperature-sensitive hydrogel composition of claim 8 , wherein the polymer material is at least one selected from the group consisting of hyaluronic acid, poly-γ-glutamic acid, cellulose, polyacrylic acid, polyamino acids, alginate, and a combination thereof.

10. A method for producing the temperature-sensitive hydrogel composition of claim 1 , the method comprising: i) dissolving the nucleic acid in a buffer solution for 1-2 hours with stirring at 60-70° C., to prepare a nucleic acid stock solution; ii) dissolving chitosan in an acidic buffer solution to prepare a chitosan stock solution; iii) mixing together the nucleic acid stock solution in step i) and the chitosan stock solution in step ii) such that the weight ratio of the nucleic acid and the chitosan is 33.333:1 to 3000:1, followed by stirring at 55-65° C. for 1-2 hours; and iv) lowering the nucleic acid-chitosan mixture liquid in step iii) to room temperature with stirring, thereby obtaining the temperature-sensitive hydrogel composition comprising a nucleic acid and chitosan.

11. The method of claim 10 , wherein the temperature-sensitive hydrogel composition has an osmotic pressure of 100-500 mOsm.

12. The method of claim 10 , wherein the temperature-sensitive hydrogel composition has a pH value of 6.5-7.5.

13. The method of claim 10 , wherein the weight ratio of the nucleic acid and the chitosan is 50:1 to 2000:1.

14. The method of claim 13 , wherein the weight ratio of the nucleic acid and the chitosan is 100:1 to 1000:1.

15. The method of claim 10 , wherein the content of the nucleic acid is 1-3 wt % relative to the total weight of the composition.

16. The method of claim 10 , wherein the nucleic acid is deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or a mixture thereof.

17. The method of claim 10 , wherein the content of the chitosan is 0.001 wt % to 0.03 wt % relative to the total weight of the composition.

18. The method of claim 10 , wherein the molecular weight of the chitosan is 3 kDa to 1,000 kDa.

19. The method of claim 10 , wherein the temperature-sensitive hydrogel composition contains a polymer material as an additional ingredient.

Assignments (2)
CHANGE OF NAME Recorded Mar 9, 2023
From: PHARMARESEARCH PRODUCTS CO., LTD.
To: PHARMARESEARCH CO., LTD.
Reel/Frame 063014/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2018
From: KIM, IK SOO; KIM, HAN GYU; HONG, CHEOL AM; LEE, SU YEON
To: PHARMARESEARCH PRODUCTS CO., LTD.
Reel/Frame 046549/0268 →
Priority Claims (1)
KR 10-2016-0015112 · Feb 5, 2016 · national
Continuity (1)
Related Publication 20190054015A1 · Feb 21, 2019